Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001232524-15-000140
Filing Date
2015-08-05
Accepted
2015-08-05 17:18:57
Documents
12
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q jazz2015q2doc.htm 10-Q 1683355
2 NON-EMPLOYEE DIRECTOR COMPENSATION POLICY jazzq22015ex102.htm EX-10.2 33030
3 NOVATION AGREEMENT jazzq22015ex103.htm EX-10.3 43734
4 CERTIFICATION OF CEO PURSUANT TO RULES 13A-14(A) AND 15D-14(A) jazzq22015ex311.htm EX-31.1 12939
5 CERTIFICATION OF CFO PURSUANT TO RULES 13A-14(A) AND 15D-14(A) jazzq22015ex312.htm EX-31.2 12129
6 CERTIFICATIONS OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350 jazzq22015ex321.htm EX-32.1 8092
  Complete submission text file 0001232524-15-000140.txt   7678602

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT jazz-20150630.xml EX-101.INS 1573664
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jazz-20150630.xsd EX-101.SCH 49009
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT jazz-20150630_cal.xml EX-101.CAL 109741
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT jazz-20150630_def.xml EX-101.DEF 237687
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jazz-20150630_lab.xml EX-101.LAB 688546
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jazz-20150630_pre.xml EX-101.PRE 396041
Mailing Address 4TH FLOOR, CONNAUGHT HOUSE ONE BURLINGTON ROAD DUBLIN L2 4
Business Address 4TH FLOOR, CONNAUGHT HOUSE ONE BURLINGTON ROAD DUBLIN L2 4 353-1-634-7800
Jazz Pharmaceuticals plc (Filer) CIK: 0001232524 (see all company filings)

EIN.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33500 | Film No.: 151029995
SIC: 2834 Pharmaceutical Preparations